Revenue and adjusted EBITDA rose significantly in the second quarter of 2026 compared to the first quarter of 2026, but ...
Personalised medicine has commercial promise, but delivering it on the packaging line is a significant challenge. At CPHI ...
The agreement will see MedPharm support the transfer and commercial manufacture of an undisclosed branded speciality topical ...
Explore the rise of AI in pharmaceutical quality and the risks of over-reliance, examining why experience, instinct and ...
The CDMO's MaruX platform, ShunzymeX purification technology and COO Maja Pedersen are all shortlisted ahead of its CPHI ...
Chris Davison, CEO of Centrix Pharma, explains why considering manufacturability early in clinical development can reduce ...
C2 Pharma has added brinzolamide to its ophthalmic API portfolio following completion of process validation and submission of ...
The expansion adds two 500-gallon reactors and enhanced early-stage containment capabilities, strengthening the Illinois site ...
Integrated system combines a 5.5 ml prefillable glass syringe with a passive safety device for large-volume and biologic ...
Most pharmaceutical companies have set ambitious decarbonisation targets, with supply-chain-related emissions accounting for ...
Thermo Fisher Scientific, the world leader in serving science, today announced the Gibco™ CHO-K1 Catalog Panel, a cGMP-ready portfolio of basal and feed media designed to support strong cell growth ...
Shilpa Biologicals has launched SB HiMax, an integrated CDMO platform designed to take monoclonal antibodies from gene to GMP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results